New Anflaz Tablet 100 mg (Sofugrelate Hydrochloride)
Sarpogrelate Hydrochloride
Prescription medication
AhnGuk New Pharm Co., Ltd.
MFDS item code 201803001 · Approved 2018.07.19
This product's status changed to Expired on 2023.07.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of ischemic symptoms associated with chronic arterial occlusion (ulcer, pain, etc.)
This medication is used to improve ischemic symptoms such as ulcers, pain, and numbness caused by chronic arterial occlusion. It alleviates blood flow disorders associated with Buerger's disease, occlusive arterial sclerosis, and diabetic peripheral vascular disease, thus reducing the symptoms of pain and discomfort, and helping to enhance the health of peripheral tissues. It contributes to improving quality of life by enhancing overall blood circulation. Therefore, it is effective for the improvement of ischemic symptoms.
As Sofugrelate Hydrochloride, take 100 mg orally three times a day after meals. Adjust dosage appropriately based on symptoms.
This medication should not be used in patients with bleeding as it may increase the risk of bleeding. It is safer for pregnant women or women who may become pregnant not to take this medication. Patients who are menstruating or have a tendency to bleed should be cautious as bleeding may worsen when taking this medication. Patients taking anticoagulants or platelet aggregation inhibitors should use this medication cautiously as the risk of bleeding may increase when used together. Patients with severely impaired renal function need to be careful as there may be issues with the excretion of this medication. Elderly patients often have decreased renal and liver function, so starting with a lower dose and closely monitoring their condition is advisable. During the use of this medication, it is crucial to closely observe for symptoms of bleeding, liver dysfunction, or blood abnormalities, and to consult a physician immediately if any abnormal symptoms appear. This medication can cause side effects such as liver dysfunction, skin rash, digestive symptoms, palpitations, and drowsiness, so if these symptoms occur, it is advised to stop taking it and consult a professional. Regular blood tests are recommended to check for bleeding tendencies and liver function. This medication must be kept out of reach of children, and care should be taken not to transfer it to another container as this may alter its quality.
Gastrointestinal bleeding (hematemesis and melena, etc.), intracerebral hemorrhage, subcutaneous bleeding, agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, urticaria
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is recommended to be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent deterioration.
This medicine is a white, round film-coated tablet.
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sarpogrelate Hydrochloride
Prescription medication
AhnGuk New Pharm Co., Ltd.
Sarpogrelate Hydrochloride
Prescription medication
Bionex Co., Ltd.
Sarpogrelate Hydrochloride
Prescription medication
iWorld Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.